| 摘要 |
<p>The present invention relates to the use of one or more compound selected from the group of statins, in particular rosuvastatin, atorvastatin, simvastatin, fluvastatin, pravastatin, and terbinafine, interferone alpha-2b, interleukin-4 (IL-4), interleukin-13 (IL-13) and other interleukin-4 receptor agonists, or a functionally equivalent analogue in the manufacture of pharmaceutical preparations for the treatment of obesity, as well as a method for treatment of obesity.</p> |
